Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Quack, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 51 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fredriksson, A; Danysz, W; Quack, G; Archer, T
      Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice

      JOURNAL OF NEURAL TRANSMISSION
    2. Kelly, JM; Quack, G; Miles, MM
      In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    3. Parsons, CG; Danysz, W; Quack, G
      Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists - in vitro characterisation

      AMINO ACIDS
    4. Danysz, W; Parsons, CG; Quack, G
      NMDA channel blockers: memantine and amino-aklylcyclohexanes - In vivo characterization

      AMINO ACIDS
    5. Albrecht, J; Hilgier, W; Zielinska, M; Januszewski, S; Hesselink, M; Quack, G
      Extracellular concentrations of taurine, glutamate, and aspartate in the cerebral cortex of rats at the asymptomatic stage of thioacetamide-induced hepatic failure: Modulation by ketamine anesthesia

      NEUROCHEMICAL RESEARCH
    6. Jirgensons, A; Kauss, V; Kalvinsh, I; Gold, MR; Danysz, W; Parsons, CG; Quack, G
      Synthesis and structure-affinity relationships of 1,3,5-alkylsubstituted cyclohexylamines binding at NMDA receptor PCP site

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    7. Wenk, GL; Quack, G; Moebius, HJ; Danysz, A
      No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use

      LIFE SCIENCES
    8. Ametamey, SM; Samnick, S; Leenders, KL; Vontobel, P; Quack, G; Parsons, CG; Schubiger, PA
      Fluorine-18 radiolabelling, biodistribution studies and preliminary pet evaluation of a new memantine derivative for imaging the NMDA receptor

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    9. Rose, C; Michalak, A; Rao, KVR; Quack, G; Kircheis, G; Butterworth, RF
      L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure

      HEPATOLOGY
    10. Parsons, CG; Danysz, W; Quack, G
      Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data

      NEUROPHARMACOLOGY
    11. Parsons, CG; Danysz, W; Bartmann, A; Spielmanns, P; Frankiewicz, T; Hesselink, M; Eilbacher, B; Quack, G
      Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonistswith strong voltage-dependency and fast blocking kinetics: in vitro and invivo characterization

      NEUROPHARMACOLOGY
    12. SAMNICK S; AMETAMEY S; LEENDERS KL; VONTOBEL P; QUACK G; PARSONS CG; NEU H; SCHUBIGER PA
      ELECTROPHYSIOLOGICAL STUDY, BIODISTRIBUTION IN MICE, AND PRELIMINARY PET EVALUATION IN A RHESUS-MONKEY OF 1-AMINO-3-[F-18]FLUOROMETHYL-5-METHYL-ADAMANTANE (F-18-MEM) - A POTENTIAL RADIOLIGAND FOR MAPPING THE NMDA-RECEPTOR COMPLEX

      Nuclear medicine and biology
    13. Wohlfrom, M; Hanke, S; Kamenz, J; Voisard, R; Heise, N; Seibold, G; Lenz, C; Quack, G; Wuhlfroth, P; Hanke, H
      Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty

      CORONARY ARTERY DISEASE
    14. LUPP A; KERST S; KARGE E; QUACK G; KLINGER W
      INVESTIGATION ON POSSIBLE ANTIOXIDATIVE PROPERTIES OF THE NMDA-RECEPTOR ANTAGONISTS KETAMINE, MEMANTINE, AND AMANTADINE IN COMPARISON TO NICANARTINE IN-VITRO

      Experimental and toxicologic pathology
    15. PARSONS CG; DANYSZ W; HESSELINK M; HARTMANN S; LORENZ B; WOLLENBURG C; QUACK G
      MODULATION OF NMDA RECEPTORS BY GLYCINE - INTRODUCTION TO SOME BASIC ASPECTS AND RECENT DEVELOPMENTS

      Amino acids
    16. DANYSZ W; PARSONS CG; KARCZKUBICHA M; SCHWAIER A; POPIK P; WEDZONY K; LAZAREWICZ J; QUACK G
      GLYCINE(B) ANTAGONISTS AS POTENTIAL THERAPEUTIC AGENTS - PREVIOUS HOPES AND PRESENT REALITY

      Amino acids
    17. ROSE C; MICHALAK A; PANNUNZIO P; THERRIEN G; QUACK G; KIRCHEIS G; BUTTERWORTH RF
      L-ORNITHINE-L-ASPARTATE IN EXPERIMENTAL PORTAL-SYSTEMIC ENCEPHALOPATHY - THERAPEUTIC EFFICACY AND MECHANISM OF ACTION

      Metabolic brain disease
    18. Pugovics, O; Kauss, V; Kalvinsh, I; Gold, MR; Quack, G
      Convenient synthesis of 2,6-di-tert-butyl-4-[5-(3-pyridyl)-4-oxapentyl]phenols and their thia-analogues

      JOURNAL OF CHEMICAL RESEARCH-S
    19. Quack, G
      Amantadine reduces motor fluctuations induced by L-Dopa - Practical and clinical results

      AKTUELLE NEUROLOGIE
    20. Karcz-Kubicha, M; Quack, G; Danysz, W
      Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats

      JOURNAL OF NEURAL TRANSMISSION
    21. ROSE C; PANNUNZIO P; MICHALAK A; QUACK G; KIRCHEIS G; BUTTERWORTH RF
      L-ORNITHINE-L-ASPARTATE LOWERS PLASMA AND CSF AMMONIA AND PREVENTS BRAIN EDEMA IN RATS WITH ACUTE LIVER-FAILURE

      Hepatology
    22. PIEPER HG; RADAS CB; QUACK G; KRAHL H
      MEDIOMALLEOLAR FRACTURE COMBINED WITH ACHILLES-TENDON RUPTURE - A RARE SIMULTANEOUS INJURY OF THE ANKLE

      International journal of sports medicine
    23. SCHOLTISSEK C; QUACK G; KLENK HD; WEBSTER RG
      HOW TO OVERCOME RESISTANCE OF INFLUENZA-A VIRUSES AGAINST ADAMANTANE DERIVATIVES

      Antiviral research
    24. PANNUNZIO P; ROSE C; MICHALAK A; QUACK G; KIRCHEIS G; BUTTERWORTH RF
      L-ORNITHINE-L-ASPARTATE IN EXPERIMENTAL PORTAL-SYSTEMIC ENCEPHALOPATHY - THERAPEUTIC EFFICACY AND MECHANISM OF ACTION

      Journal of neurochemistry
    25. VOGELS BAPM; MAAS MAW; DAALHUISEN J; QUACK G; CHAMULEAU RAFM
      MEMANTINE, A NONCOMPETITIVE NMDA RECEPTOR ANTAGONIST IMPROVES HYPERAMMONEMIA-INDUCED ENCEPHALOPATHY AND ACUTE HEPATIC-ENCEPHALOPATHY IN RATS

      Hepatology
    26. DANYSZ W; PARSONS CG; KORNHUBER J; SCHMIDT WJ; QUACK G
      AMINOADAMANTANES AS NMDA RECEPTOR ANTAGONISTS AND ANTIPARKINSONIAN AGENTS - PRECLINICAL STUDIES

      Neuroscience and biobehavioral reviews
    27. PARSONS CG; DANYSZ W; QUACK G; HARTMANN S; LORENZ B; WOLLENBURG C; BARAN L; PRZEGALINSKI E; KOSTOWSKI W; KRZASCIK P; CHIZH B; HEADLEY PM
      NOVEL SYSTEMICALLY ACTIVE ANTAGONISTS OF THE GLYCINE SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR - ELECTROPHYSIOLOGICAL, BIOCHEMICAL AND BEHAVIORAL CHARACTERIZATION

      The Journal of pharmacology and experimental therapeutics
    28. LANGE M; QUACK G; HEINLE H
      INFLUENCE OF ANTIOXIDANTS ON ARTERIAL ELASTICITY IN HYPERCHOLESTEROLEMIC RABBITS

      Atherosclerosis
    29. ALBRECHT J; HILGIER W; JANUSZEWSKI S; QUACK G
      CONTRASTING EFFECTS OF THIOACETAMIDE-INDUCED LIVER-DAMAGE ON THE BRAIN UPTAKE INDEXES OF ORNITHINE, ARGININE AND LYSINE - MODULATION BY TREATMENT WITH ORNITHINE ASPARTATE

      Metabolic brain disease
    30. ZAJACZKOWSKI W; QUACK G; DANYSZ W
      INFUSION OF (-MK-801 AND MEMANTINE - CONTRASTING EFFECTS ON RADIAL MAZE-LEARNING IN RATS WITH ENTORHINAL CORTEX LESION())

      European journal of pharmacology
    31. QUACK G; WILLMANN G; KRAHL H; GRUNDEI H
      DESIGN CONSIDERATION TO IMPROVE THE ACETA BULAR CUP OF THE ESKA-THR SYSTEM BY USING THE WEAR COUPLE CERAMIC-ON-CERAMIC

      Biomedizinische Technik
    32. HEINLE H; WULFROTH P; QUACK G; LANG F
      EFFECTS OF THE NEW ANTIOXIDANT NICANARTINE IN AN EXPERIMENTAL-MODEL OF ATHEROSCLEROSIS

      Arzneimittel-Forschung
    33. BOCOS C; OROZCO E; CASTRO W; QUACK G; HERRERA E
      EFFECT OF ETOFIBRATE ON BILE PRODUCTION IN THE NORMOLIPIDEMIC RAT

      General pharmacology
    34. KORNHUBER J; QUACK G
      CEREBROSPINAL-FLUID AND SERUM CONCENTRATIONS OF THE N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONIST MEMANTINE IN MAN

      Neuroscience letters
    35. QUACK G; HESSELINK M; DANYSZ W; SPANAGEL R
      MICRODIALYSIS STUDIES WITH AMANTADINE AND MEMANTINE ON PHARMACOKINETICS AND EFFECTS ON DOPAMINE TURNOVER

      Journal of neural transmission. Supplementum
    36. MULLER T; KUHN W; QUACK G; PRZUNTEK H
      INTRAVENOUS APPLICATION OF AMANTADINE AND ANTIPARKINSONIAN EFFICACY IN PARKINSONIAN-PATIENTS

      Journal of neural transmission. Supplementum
    37. QUACK G; KRAHL H; ALBERTI W
      PROPHYLAXIS OF PERIARTICULAR OSSIFICATION FOLLOWING TOTAL HIP-REPLACEMENT

      Der Orthopade
    38. KRAHL H; PIEPER HG; QUACK G
      BONE HYPERTROPHY AS A RESULT OF TRAINING STRAIN

      Der Orthopade
    39. KORNHUBER J; QUACK G; DANYSZ W; JELLINGER K; DANIELCZYK W; GSELL W; RIEDERER P
      THERAPEUTIC BRAIN CONCENTRATION OF THE NMDA RECEPTOR ANTAGONIST AMANTADINE

      Neuropharmacology
    40. PARSONS CG; QUACK G; BRESINK I; BARAN L; PRZEGALINSKI E; KOSTOWSKI W; KRZASCIK P; HARTMANN S; DANYSZ W
      COMPARISON OF THE POTENCY, KINETICS AND VOLTAGE-DEPENDENCY OF A SERIES OF UNCOMPETITIVE NMDA RECEPTOR ANTAGONISTS IN-VITRO WITH ANTICONVULSIVE AND MOTOR IMPAIRMENT ACTIVITY IN-VIVO

      Neuropharmacology
    41. ALBERTI W; QUACK G; KRISCHKE W; LOMMATZSCH A; HUYER C; KRAHL H
      PREVENTION OF HETEROTOPIC BONE-FORMATION BY RADIATION-THERAPY AFTER TOTAL HIP-ARTHROPLASTY

      Deutsche Medizinische Wochenschrift
    42. SLOTBOOM J; VOGELS BAPM; DEHAAN JG; CREYGHTON JHN; QUACK G; CHAMULEAU RAFM; BOVEE WMMJ
      PROTON-RESONANCE SPECTROSCOPY STUDY OF THE EFFECTS OF L-ORNITHINE-L-ASPARTATE ON THE DEVELOPMENT OF ENCEPHALOPATHY, USING LOCALIZATION PULSES WITH REDUCED SPECIFIC ABSORPTION RATE

      Journal of magnetic resonance. Series B
    43. ALBRECHT J; HILGIER W; JANUSZEWSKI S; KAPUSCINSKI A; QUACK G
      INCREASE OF THE BRAIN UPTAKE INDEX FOR L-ORNITHINE IN RATS WITH HEPATIC-ENCEPHALOPATHY

      NeuroReport
    44. DANYSZ W; GOSSEL M; ZAJACZKOWSKI W; DILL D; QUACK G
      ARE NMDA ANTAGONISTIC PROPERTIES RELEVANT FOR ANTIPARKINSONIAN-LIKE ACTIVITY IN RATS - CASE OF AMANTADINE AND MEMANTINE

      Journal of neural transmission. Parkinson's disease and dementia section
    45. KRAHL H; MICHAELIS U; PIEPER HG; QUACK G; MONTAG M
      STIMULATION OF BONE-GROWTH THROUGH SPORTS - A RADIOLOGIC INVESTIGATION OF THE UPPER EXTREMITIES IN PROFESSIONAL TENNIS PLAYERS

      American journal of sports medicine
    46. SKUZA G; ROGOZ Z; QUACK G; DANYSZ W
      MEMANTINE, AMANTADINE, AND L-DEPRENYL POTENTIATE THE ACTION OF L-DOPAIN MONOAMINE-DEPLETED RATS

      Journal of neural transmission
    47. HONEGGER UE; QUACK G; WIESMANN UN
      EVIDENCE FOR LYSOSOMOTROPISM OF MEMANTINE IN CULTURED HUMAN-CELLS - CELLULAR KINETICS AND EFFECTS OF MEMANTINE ON PHOSPHOLIPID CONTENT AND COMPOSITION, MEMBRANE FLUIDITY AND BETA-ADRENERGIC TRANSMISSION

      Pharmacology & toxicology
    48. MORYL E; DANYSZ W; QUACK G
      POTENTIAL ANTIDEPRESSIVE PROPERTIES OF AMANTADINE, MEMANTINE AND BIFEMELANE

      Pharmacology & toxicology
    49. PARSONS CG; QUACK G
      EFFECTS OF N-METHYL-D-ASPARTATE ANTAGONISTS IN DEMENTIA

      Journal of neurochemistry
    50. BOCOS C; CASTRO M; QUACK G; HERRERA E
      STUDIES WITH ETOFIBRATE IN THE RAT .2. A COMPARISON OF THE EFFECTS OFPROLONGED AND ACUTE ADMINISTRATION ON PLASMA-LIPIDS, LIVER-ENZYMES AND ADIPOSE-TISSUE LIPOLYSIS

      Biochimica et biophysica acta
    51. WULFROTH P; RICHTER CM; BURKARD M; HUTH K; QUACK G
      ETOFIBRATE TREATMENT ALTERS LOW-DENSITY-LIPOPROTEIN SUSCEPTIBILITY TOLIPID-PEROXIDATION

      Drugs under experimental and clinical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 11:06:48